Loading...

Home
Stock
QNCX

QNCX News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings Should I Buy News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

QNCX News

Wall Street Analysts Adjust Ratings

Jan 30 2026Benzinga

Quince Therapeutics Shares Plunge 90% After Disappointing Phase 3 Trial Results

Jan 30 2026Benzinga

Quince's Clinical Trial Fails to Meet Key Endpoints

Jan 29 2026stocktwits

Quince Therapeutics Reports Phase 3 Trial Results for A-T Treatment

Jan 29 2026Businesswire

Quince Therapeutics' Clinical Trial Fails to Meet Primary Endpoint

Jan 29 2026Newsfilter

Quince Completes A-T Phase 3 Trial, Expects Results in Q1 2026

Dec 15 2025Newsfilter

Quince Therapeutics Publishes eDSP Clinical Study Results, Showcasing Broad Application Potential

Dec 10 2025Newsfilter

Monday's Underperforming Sectors: Biotechnology, Electronic Equipment, and Products

Dec 01 2025NASDAQ.COM

QNCX Events

No data

No data

QNCX Monitor News

Quince Therapeutics' Phase 3 Trial Fails, Stock Plummets

Quince Therapeutics' Clinical Trial Fails, Stock Drops Significantly

QNCX Earnings Analysis

No Data

No Data

People Also Watch